Hyderabad |Sunday, 2021 1:45:06 AM ISTAimed at demonstrating data generation and data transparency, Covaxin maker Bharat Biotech on Saturday said that the company has published nine research studies on the safety and efficacy of its vaccine in a year.... read..
By Sahil PandeyNew Delhi | June 12, 2021 6:14:39 PM ISTBharat Biotech on Saturday shared full data of all research studies of its Covaxin-- India's first indigenous COVID-19 vaccine.... read..
By Sahil PandeyPennsylvania | June 11, 2021 2:14:43 PM ISTBharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Application (BL... read..
New Delhi |Friday, 2021 7:45:06 PM ISTThe US Food and Drug administration has denied approval for emergency use of Covaxin, developed by Hyderabad-based Bharat Biotech, and has asked for additional data, biopharmaceutical Ocugen, the US partner of the Indian vaccine maker has said.... read..
New Delhi |Friday, 2021 9:15:06 PM ISTA day after the US Food and Drug administration (FDA) denied approval for emergency use of Covaxin, the Hyderabad-based Bharat Biotech on Friday said that it is following the recommendation for additional data and will work for full approval.... read..
Hyderabad |Friday, 2021 10:15:06 PM ISTWith the US Food and Drug Administration (US FDA) recommending Ocugen Inc, the US partner of Bharat Biotech, to go for Biologics License Application (BLA) instead of Emergency Use Authorisation (EUA), the launch of the first indigenous Indian Covid-19 vac... read..
New Delhi/Hyderabad |Friday, 2021 10:45:05 PM ISTA day after the US Food and Drug administration (FDA) denied approval for emergency use of Covaxin, the Hyderabad-based Bharat Biotech on Friday said that it is following the recommendation for additional data and will work for full approval.... read..
By Sahil PandeyNew Delhi | June 11, 2021 7:14:39 PM ISTReacting to the United States Food and Drug Administration (FDA)'s rejection of Bharat Biotech's Covaxin jab for emergency use authorization, the Union Health Ministry on Friday said that it respects the decision taken by the authority but it will not hav... read..
Hyderabad |Thursday, 2021 8:45:06 PM ISTThe results of third phase trials of India's first indigenously developed Covid-19 vaccine Covaxin are expected to be released next month.... read..
By Shalini BhardwajNew Delhi | June 10, 2021 4:44:39 PM ISTAs people are struggling to book slots for COVID-19 vaccination in their cities, many of them who are in less than 45 years age group from Delhi-NCR are travelling a long distance to get their first and even second dose of COVAXIN.... read..
By Shalini BhardwajNew Delhi | June 9, 2021 6:14:43 PM ISTHyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of COVAXIN.... read..
New Delhi | June 8, 2021 10:44:27 PM ISTAs part of the revised COVID-19 vaccine policy, the Centre on Tuesday issued an order capping the prices for administration of three approved coronavirus vaccines in private hospitals across the country.... read..
New Delhi | June 8, 2021 6:14:42 PM ISTThe Union Health Ministry on Tuesday informed that the Centre has placed an order to purchase 25 crores doses of Covishield and 19 crore doses of Covaxin.... read..
New Delhi |Tuesday, 2021 2:15:06 AM ISTThe Delhi government has received 40,000 doses of Covaxin from the Centre for the 18-44 age group, but this will be administered only as the second dose, AAP lawmaker Atishi said on Monday.... read..
By Amiya Kumar KushwahaNew Delhi | June 7, 2021 4:14:35 PM ISTThe Delhi government on Monday informed the Delhi High Court that it has directed that all private hospitals and nursing homes functioning as COVID vaccination centres to ensure that the Covaxin will be used to vaccinate only those people (of age group 18... read..
New Delhi |Monday, 2021 2:15:05 AM ISTA latest study has found that both vaccines, Covishield and Covaxin elicited good immune response after two doses, although seropositivity rates and median anti-spike antibody titre was significantly higher in Covishield as compared to Covaxin.... read..
New Delhi | June 6, 2021 10:44:27 PM ISTThe Delhi government on Sunday ordered all private hospitals and nursing homes, functioning as COVID vaccination centres for Covaxin, to ensure that the doses are used only to vaccinate those people from 18-44 age group who are eligible for receiving the ... read..
By Shalini BhardwajNew Delhi | June 6, 2021 11:14:35 PM ISTThe All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous home-grown COVID-19 vaccine, Bharat Biotech's Covaxin, from Monday, sources said.... read..